| Name | Lenscrafters #9560 |
|---|---|
| Organization Name | Luxottica Of America Inc |
| Location | 575 E University Pkwy, Orem, Utah 84097 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (801) 788-3832 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Ever worried that all the information you've crammed in during a study session might not stay in your memory? The answer might be going for a run, according to a new study published in Cognitive Systems Research.
People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A new Tel Aviv University study finds that a popular food supplement called phosphatidylserine may be instrumental in reversing the detrimental effects of Familial Dysautonomia (FD), a debilitating neurodegenerative disorder that affects approximately 1 in 31 Jewish people of Eastern European, or Ashkenazi, ancestry.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.
› Verified 5 days ago
| NPI Number | 1184280935 |
| Organization Name | LUXOTTICA OF AMERICA INC. |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 575 E University Pkwy Ste E100, Orem, UT 84097 |
| Phone Number | 801-788-3832 |
News Archive
Ever worried that all the information you've crammed in during a study session might not stay in your memory? The answer might be going for a run, according to a new study published in Cognitive Systems Research.
People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A new Tel Aviv University study finds that a popular food supplement called phosphatidylserine may be instrumental in reversing the detrimental effects of Familial Dysautonomia (FD), a debilitating neurodegenerative disorder that affects approximately 1 in 31 Jewish people of Eastern European, or Ashkenazi, ancestry.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.
› Verified 5 days ago
News Archive
Ever worried that all the information you've crammed in during a study session might not stay in your memory? The answer might be going for a run, according to a new study published in Cognitive Systems Research.
People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A new Tel Aviv University study finds that a popular food supplement called phosphatidylserine may be instrumental in reversing the detrimental effects of Familial Dysautonomia (FD), a debilitating neurodegenerative disorder that affects approximately 1 in 31 Jewish people of Eastern European, or Ashkenazi, ancestry.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.
› Verified 5 days ago
Petersen Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1268 S 1380 W, Orem, Utah 84058 Phone: (801) 374-8101 | |
Hanger Clinc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1415 S State St, Orem, Utah 84097 Phone: (801) 356-1830 | |
Harmons Pharmacy 88 Type: Community/Retail Pharmacy Location: 870 E 800 N, Orem, Utah 84097 Phone: (801) 714-4150 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1442 W Business Park Dr, Orem, Utah 84058 Phone: (801) 224-3338 | |
Lenscrafters #9560 Type: Eyewear Supplier (Equipment, not the service) Location: 575 E University Pkwy, Orem, Utah 84097 Phone: (801) 788-3832 |